{
    "paper_id": "PMC7120553",
    "metadata": {
        "title": "Neonatal Emergencies",
        "authors": [
            {
                "first": "Suresh",
                "middle": [
                    "S"
                ],
                "last": "David",
                "suffix": "",
                "email": "suresh.david@pushpagiri.in",
                "affiliation": {}
            },
            {
                "first": "Christina",
                "middle": [
                    "L."
                ],
                "last": "Cochran",
                "suffix": "",
                "email": "CCochran@luriechildrens.org",
                "affiliation": {}
            },
            {
                "first": "Parul",
                "middle": [
                    "P."
                ],
                "last": "Soni",
                "suffix": "",
                "email": "PSoni@luriechildrens.org",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\nNeonatal Resuscitation Program (NRP) guidelines should be employed for management of a newborn in distress [1].Always consider nonaccidental trauma in newborns presenting to the emergency department (ED).Prognosis is often dependent on the underlying aetiology or degree of illness.Overall, early recognition and management will improve long-term outcome.\n",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 110,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Key Points",
            "ref_spans": []
        },
        {
            "text": "Newborns presenting with respiratory illness should be evaluated promptly as respiratory failure can precipitate quickly. There are many aetiologies of respiratory illness in the newborn period, of which the most common will be reviewed.",
            "cite_spans": [],
            "section": "Introduction ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": []
        },
        {
            "text": "\nRespiratory distress syndrome (RDS) is caused by insufficient surfactant production, most commonly in preterm infants.Insufficient surfactant causes inappropriate alveolar expansion.Decreased alveolar expansion leads to respiratory distress.\nBronchiolitis is the result of a viral infection affecting the lower respiratory tree.Bronchioles become inflamed and increase secretion production.Common viral aetiologies include respiratory syncytial virus, human metapneumovirus, rhinovirus, enterovirus, and coronavirus [2].\nMeconium aspiration syndrome (MAS) results from aspiration of meconium at the time of delivery.\n",
            "cite_spans": [
                {
                    "start": 518,
                    "end": 519,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Pathophysiology ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": []
        },
        {
            "text": "\nInitial signs of respiratory distress include tachypnoea and increased work of breathing (Table 11.1)\nAs distress progresses, newborns are at risk of developing respiratory failure and apnoea.RDS presents in the first days of life (Table 11.2)\nBronchiolitis is a clinical diagnosis based on physical exam and history [3].Newborns will have increased work of breathing with crepitations and rhonchi on exam.\n\n",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 320,
                    "mention": "3",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Clinical Features ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": [
                {
                    "start": 97,
                    "end": 101,
                    "mention": "11.1",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 239,
                    "end": 243,
                    "mention": "11.2",
                    "ref_id": "TABREF5"
                }
            ]
        },
        {
            "text": "\nConsider RDS, bronchiolitis, sepsis, bronchopulmonary dysplasia (BPD), pulmonary hypertension, pneumonia, MAS, and pertussis.History of meconium presence in amniotic fluids should raise concern for MAS.When considering pulmonary hypertension, conduct thorough cardiac evaluation.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": []
        },
        {
            "text": "\nChest radiograph (CXR) should be obtained in patients suspected to have RDS, pneumonia, and foreign body aspiration (Table 11.3).\nCXR is not indicated in patients with bronchiolitis [3].Obtain nasal secretions to confirm pertussis infection.If suspected, infectious workup should be completed including blood, urine, and cerebrospinal fluid studies (CSF).\n",
            "cite_spans": [
                {
                    "start": 184,
                    "end": 185,
                    "mention": "3",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Investigations ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": [
                {
                    "start": 124,
                    "end": 128,
                    "mention": "11.3",
                    "ref_id": "TABREF6"
                }
            ]
        },
        {
            "text": "\nIntervention can be tailored to a degree of respiratory distress (Table 11.4).\nSurfactant should be provided to patients with RDS [4].Supportive care, including suctioning and supplemental oxygen, is the treatment of choice for bronchiolitis.Salbutamol, normal saline, and hypertonic saline nebulisers have not been shown to improve outcome in bronchiolitis [3].\nFor patients without clear viral aetiology, consider antibiotic coverage.If suspicious for pertussis, start prophylactic antibiotics.\n",
            "cite_spans": [
                {
                    "start": 132,
                    "end": 133,
                    "mention": "4",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 360,
                    "end": 361,
                    "mention": "3",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Treatment ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": [
                {
                    "start": 73,
                    "end": 77,
                    "mention": "11.4",
                    "ref_id": "TABREF7"
                }
            ]
        },
        {
            "text": "\nNewborns in respiratory distress will require observation and treatment on an inpatient service.Newborns with severe RDS are at risk of requiring long-term supplemental oxygen and developing BPD.Bronchiolitis has an overall good prognosis with resolution of symptoms once the virus infection resolves.\n",
            "cite_spans": [],
            "section": "Prognosis ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": []
        },
        {
            "text": "\nPrevention of bronchiolitis focuses on reducing virus transmission.Avoidance of preterm delivery unless clinically indicated will decrease the risk of RDS.\n",
            "cite_spans": [],
            "section": "Prevention ::: Section A: Common Assessment and Treatment Elements",
            "ref_spans": []
        },
        {
            "text": "Congenital cardiac deformities may present in the first hours to days to weeks of life. Prompt recognition of a cardiac aetiology is imperative, as management from cardiogenic shock differs from management of other aetiologies of newborn shock.",
            "cite_spans": [],
            "section": "Introduction ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nCongenital heart defects are a result of abnormal embryogenesisDefects can be classified as cyanotic (Table 11.5) and non-cyanotic (Table 11.6).\n\nCyanosis is a result of right to left shunting of non-oxygenated blood into systemic circulation.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": [
                {
                    "start": 109,
                    "end": 113,
                    "mention": "11.5",
                    "ref_id": "TABREF8"
                },
                {
                    "start": 139,
                    "end": 143,
                    "mention": "11.6",
                    "ref_id": "TABREF9"
                }
            ]
        },
        {
            "text": "\nNewborns may present with a variety of findings (Table 11.7).\n\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": [
                {
                    "start": 56,
                    "end": 60,
                    "mention": "11.7",
                    "ref_id": "TABREF10"
                }
            ]
        },
        {
            "text": "\nSerious bacterial infection (SBI) should be considered in all neonates presenting to the ED.Metabolic abnormalities, respiratory infections, and feeding difficulties can present similarly.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nAssess colour of the newborn and central/peripheral pulses (Fig. 11.1).\nMeasure four extremity blood pressures and pulse oximetry.In the setting of coarctation, lower extremity blood pressures and pulse oximetry will be decreased compared to right upper extremity.\nCXR should be obtained to assess the cardiac silhouette.Obtain electrocardiogram to assess for rhythm disturbances.Echocardiogram is used to assess cardiac anatomy and function.Consider blood gas to assess pH and arterial oxygenation.Detailed maternal and prenatal history, including ultrasound results, should be gathered.Many maternal conditions and medications can be associated with congenital heart disease [5].\n\n",
            "cite_spans": [
                {
                    "start": 679,
                    "end": 680,
                    "mention": "5",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Investigations ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": [
                {
                    "start": 66,
                    "end": 70,
                    "mention": "11.1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "\nSupplemental oxygen should be provided.Haemodynamic support should be provided with fluids, inotropes, and chronotropes as clinically indicated.The degree of fluid resuscitation is dependent on the underlying cardiac defect.\nProstaglandins should be initiated to delay closure of the ductus arteriosus in patients suspected of having a shunt-dependent defect.Initial dose \u2013 Prostaglandin E1: 0.05 mcg/kg/min\nInitiate inhaled nitric oxide if pulmonary hypertension is suspected.Cardiology consult should be obtained as soon as cardiac defect is suspected.\n",
            "cite_spans": [],
            "section": "Treatment ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nImproved management of maternal diabetes and hypertension may decrease congenital heart defects.\n",
            "cite_spans": [],
            "section": "Prevention ::: Section B : Neonatal Cardiac Emergencies",
            "ref_spans": []
        },
        {
            "text": "Any newborn with concern for infectious process should be evaluated and treated immediately. SBIs in neonates include, but not limited to, urinary tract infections (UTIs), bacteraemia, sepsis, meningitis, pneumonia, pyelonephritis, and cellulitis. Neonates with bacterial infection are at high risk for long-term morbidity and mortality [6]. Low threshold for workup of an SBI should be maintained when evaluating children less than 29 days old.",
            "cite_spans": [
                {
                    "start": 338,
                    "end": 339,
                    "mention": "6",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Introduction ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": []
        },
        {
            "text": "\nNewborns have reduced defence against bacterial infections secondary to an immature immune system.The two most common bacteria responsible for infection in newborns are group B streptococcus (GBS) and Escherichia coli (E. coli) [7].UTIs are the most common bacterial infection in this patient group.Necrotising enterocolitis (NEC) is a result of intestinal ischaemia, leading to bacterial overgrowth and gut necrosis [8].\n",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 231,
                    "mention": "7",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 419,
                    "end": 420,
                    "mention": "8",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Pathophysiology ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": []
        },
        {
            "text": "\nRectal temperature greater than 38\u00b0 C is suggestive of infection.Infants may present with hypothermia, lethargy, increased sleeping, poor feeding, jaundice, vomiting, changes in their respiratory pattern, or abnormal vital signs.Detailed prenatal and antenatal history should be obtained.Risk factors for infection include prolonged rupture of membranes, maternal fever, maternal infection, and lack of appropriate treatment for maternal GBS.\nAbdominal tenderness, distension, vomiting, bloody stool, and lethargy may indicate NEC.Redness, tenderness, or drainage from the umbilicus is concerning for omphalitis.\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": []
        },
        {
            "text": "\nConsider hypoglycaemia, metabolic dysfunction, hyperbilirubinemia, congenital heart conditions, and neurologic dysfunction when assessing a patient with the above features.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": []
        },
        {
            "text": "\nWorkup should include CBC, blood culture, urinalysis, urine culture, and CSF studies including cell count, differential, glucose, protein, and culture.Consider obtaining herpes simplex virus (HSV) tests.In the setting of omphalitis, send culture of umbilical discharge.Obtain cultures prior to antibiotic initiation unless patient is clinically decompensating.For patients with dehydration or concern for metabolic abnormalities, obtain electrolytes and liver function panel.CXR should be considered in newborns with respiratory distress, and hypoxia.NEC diagnosis and management is reviewed in Table 11.11 [9].\n",
            "cite_spans": [
                {
                    "start": 609,
                    "end": 610,
                    "mention": "9",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Investigations ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": [
                {
                    "start": 602,
                    "end": 607,
                    "mention": "11.11",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "\nPrompt antibiotic therapy is essential.Initiate broad-spectrum antibiotic coverage with ampicillin and gentamicin and/or cefotaxime.Ampicillin, gentamicin, and cefotaxime dosing is dependent on age and weight [10].Acyclovir covers for possible HSV infection: 20 mg/kg/dose every 8 h [10].\nContinue antibiotics until CSF, blood, and urine cultures have resulted.NEC management is reviewed in Table 11.11.\n",
            "cite_spans": [
                {
                    "start": 211,
                    "end": 213,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 285,
                    "end": 287,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Treatment ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": [
                {
                    "start": 398,
                    "end": 403,
                    "mention": "11.11",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "\nAppropriate treatment of maternal GBS infections reduces the likelihood of newborn infection [11].\n",
            "cite_spans": [
                {
                    "start": 95,
                    "end": 97,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Prevention ::: Section C: Serious Bacterial Infections (SBI)",
            "ref_spans": []
        },
        {
            "text": "There are a variety of gastrointestinal (GI) emergencies that may present in the newborn period. The majority of diagnoses can be distinguished based on physical exam and radiologic evaluation. Omphalocele and gastroschisis are not discussed in depth, but ED physicians should be aware of these complications.",
            "cite_spans": [],
            "section": "Introduction ::: Section D: Newborn Gastrointestinal Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nMost newborns develop clinical hyperbilirubinemia [12].Most cases of hyperbilirubinemia are physiologic, or secondary to normal delayed conjugation and excretion of bilirubin in the newborn, though pathologic aetiologies must be considered.Factors contributing to higher bilirubin levels are listed in Table 11.8.\nPatients can be classified into low risk, medium risk, or high risk for complications of bilirubin (Table 11.9) [12].\n\n",
            "cite_spans": [
                {
                    "start": 52,
                    "end": 54,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 428,
                    "end": 430,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Pathophysiology ::: Hyperbilirubinemia",
            "ref_spans": [
                {
                    "start": 309,
                    "end": 313,
                    "mention": "11.8",
                    "ref_id": "TABREF11"
                },
                {
                    "start": 421,
                    "end": 425,
                    "mention": "11.9",
                    "ref_id": "TABREF12"
                }
            ]
        },
        {
            "text": "\nNewborns with hyperbilirubinemia will appear jaundiced and may have decreased activity and desire to feed.Jaundice occurs in a cranial to caudal progression and presents within the first week of life, with peak from day 3 to 5.Jaundice presenting within the first 24 h of life is likely pathologic.\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Hyperbilirubinemia",
            "ref_spans": []
        },
        {
            "text": "\nConsider underlying genetic abnormalities, including Gilbert, Crigler-Najjar, and Dubin-Johnson, when diagnosing unconjugated hyperbilirubinemia.Also consider causes of elevated direct/conjugated bilirubin, including biliary atresia.Infection and sepsis can lead to increased bilirubin levels.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Hyperbilirubinemia",
            "ref_spans": []
        },
        {
            "text": "\nLaboratory workup will demonstrate elevated unconjugated bilirubin levels.Consider blood type testing, direct bilirubin level, complete blood count, blood smear, liver function panel, and infectious workup.\n",
            "cite_spans": [],
            "section": "Investigations ::: Hyperbilirubinemia",
            "ref_spans": []
        },
        {
            "text": "\nTreatment for hyperbilirubinemia is based on age, risk factors, and level of bilirubin (Table 11.10).\nThe goal of treatment is to prevent encephalopathy secondary to bilirubin deposition in the brain or kernicterus [12].Initial intervention includes oral hydration, intravenous (IV) hydration, and phototherapy.For high-risk cases or concern for kernicterus, exchange transfusion is employed [12].\n",
            "cite_spans": [
                {
                    "start": 217,
                    "end": 219,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 394,
                    "end": 396,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Treatment ::: Hyperbilirubinemia",
            "ref_spans": [
                {
                    "start": 95,
                    "end": 100,
                    "mention": "11.10",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "\nOverall prognosis of hyperbilirubinemia is very good [12].The incidence of kernicterus is declining with the advent of phototherapy and exchange transfusion, though patients with kernicterus continue to have long-term neurologic morbidities [12, 13].\n",
            "cite_spans": [
                {
                    "start": 55,
                    "end": 57,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 243,
                    "end": 245,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 247,
                    "end": 249,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Prognosis ::: Hyperbilirubinemia",
            "ref_spans": []
        },
        {
            "text": "\nPrevention of hyperbilirubinemia focuses on appropriate hydration of the newborn and appropriate treatment of maternal infections at the time of delivery.Awareness of risk factors will assist in early recognition and intervention.Kernicterus is an entirely preventable disease though not reversible [12].\n",
            "cite_spans": [
                {
                    "start": 301,
                    "end": 303,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Prevention ::: Hyperbilirubinemia",
            "ref_spans": []
        },
        {
            "text": "\nDuodenal atresia occurs when there is an occlusion of the duodenum, restricting passage of materials through the small bowel.Overall incidence is reported at 1 in 6,000 births [14]This diagnosis is highly associated with trisomy 21.\n",
            "cite_spans": [
                {
                    "start": 178,
                    "end": 180,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Pathophysiology ::: Duodenal Atresia",
            "ref_spans": []
        },
        {
            "text": "\nPatients will present in the first days of life with bilious vomiting.Physical exam may reveal a scaphoid abdomen.Newborn may pass meconium but is unlikely to have any bowel movements.Prenatal history is often positive for polyhydramnios.\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Duodenal Atresia",
            "ref_spans": []
        },
        {
            "text": "\nInfection, oesophageal atresia, tracheaoesophageal fistula, pyloric stenosis, and reflux should be considered.Vomiting in the setting of duodenal atresia is bilious in nature, distinguishing this diagnosis from many others.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Duodenal Atresia",
            "ref_spans": []
        },
        {
            "text": "\nAbdominal x-ray will reveal a double bubble sign indicating trapped air in the stomach and proximal duodenum.Electrolytes, including glucose, should be obtained to assess hydration and nutritional status.\n",
            "cite_spans": [],
            "section": "Investigations ::: Duodenal Atresia",
            "ref_spans": []
        },
        {
            "text": "\nManagement of duodenal atresia is reviewed in Table 11.11.\n\n",
            "cite_spans": [],
            "section": "Treatment ::: Duodenal Atresia",
            "ref_spans": [
                {
                    "start": 53,
                    "end": 58,
                    "mention": "11.11",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "\nComplications may include dependence of parenteral nutrition, poor growth, perforation of the duodenum, and stricture at the site of anastomosis [15].\n",
            "cite_spans": [
                {
                    "start": 147,
                    "end": 149,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Prognosis ::: Duodenal Atresia",
            "ref_spans": []
        },
        {
            "text": "\nHirschsprung\u2019s disease is the result of failed migration of neural crest cells leading to a lack of innervation in a section of the colon.The aganglionic colon is unable to relax, leading to constriction of that segment.Hirschsprung\u2019s disease is more common in males with a 4:1 male to female predominance [16].\n",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 310,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Pathophysiology ::: Hirschsprung\u2019s Disease",
            "ref_spans": []
        },
        {
            "text": "\nMost newborns present with delayed passage of meconium and stool.Ninety-eight percent of normal newborns pass meconium within 48 h.\nNewborns may present with abdominal distension, vomiting, or stringy stoolsPhysical exam reveals a tight anal sphincter and explosive stooling with rectal exam.Patients may present with toxic megacolon \u2013 extreme dilation of the colon leading to distension, pain, perforation, and shock.\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Hirschsprung\u2019s Disease",
            "ref_spans": []
        },
        {
            "text": "\nConsider constipation, meconium ileus, duodenal atresia, or other intestinal obstruction.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Hirschsprung\u2019s Disease",
            "ref_spans": []
        },
        {
            "text": "\nRectal suction biopsy of the narrowed section of the colon is gold standard for diagnosis [17].Anal manometry and barium enema can assist with diagnosis.If toxic megacolon is suspected, obtain abdominal x-ray, electrolytes, complete blood count, and blood culture.\n",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 94,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Investigations ::: Hirschsprung\u2019s Disease",
            "ref_spans": []
        },
        {
            "text": "\nManagement of Hirschsprung\u2019s Disease is reviewed in Table 11.11\nIn the case of toxic megacolon, provide resuscitation as clinically indicated and IV antibiotics\n",
            "cite_spans": [],
            "section": "Treatment ::: Hirschsprung\u2019s Disease",
            "ref_spans": [
                {
                    "start": 59,
                    "end": 64,
                    "mention": "11.11",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "\nLong-term complications of Hirschsprung\u2019s disease include constipation, bowel dysfunction, and toxic megacolon [17].\n",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 115,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Prognosis ::: Hirschsprung\u2019s Disease",
            "ref_spans": []
        },
        {
            "text": "Metabolic disorders can masquerade as many different diagnoses on initial presentation. In newborns, always consider underlying metabolic disorders such as congenital adrenal hyperplasia (CAH), thyroid dysfunction, fatty acid disorders, amino acid disorders, urea cycle disorders, organic acid disorders, and glycogen storage disease.",
            "cite_spans": [],
            "section": "Introduction ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nMetabolic emergencies in a newborn result from a range of disorders and deficiencies.Pathophysiology is entirely dependent on the underlying disorder.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nNewborns may present with poor weight gain, feeding difficulties, lethargy, emesis, diarrhoea, and decreased movement.Female and male infants with CAH present with slight variation [18].Females will likely have ambiguous genitalia with enlarged clitoris.Males tend to present with salt wasting and electrolyte abnormalities including hyponatremia and hypokalaemia.\n\n",
            "cite_spans": [
                {
                    "start": 183,
                    "end": 185,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Clinical Features ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nConsider sepsis, genetic disorders, and cardiac abnormalities in these patients.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nNewborn screening results should be reviewed.Glucose levels should be obtained immediately.Blood gas should be obtained to assess for signs of metabolic acidosis or alkalosis.Multiple metabolic disorders can present with electrolyte derangement.Obtain ACTH, cortisol, and 17-hydroxyprogesterone levels if concerned for CAH [18].Consider urine organic acids, serum amino acids, acylcarnitine profile, lactate, and pyruvate in non-emergent phase.Consider thyroid studies in patients with clinical signs or maternal history of antithyroid antibodies.\n",
            "cite_spans": [
                {
                    "start": 325,
                    "end": 327,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Investigations ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nProvide dextrose for patients with hypoglycaemia defined as less than 2.6 mmol/L or symptomatic.Oral feeds with dextrose (milk, formula) if patient tolerates.IV dextrose 10 % bolus of 2 ml/kg.If blood sugar remains low, consider an IV infusion of 10 % dextrose.\nConsider stress-dose steroids if CAH and adrenal crisis are suspected [10].Hydrocortisone IV: 50\u2013100 mg/m2\n\nCorrect electrolyte abnormalities as indicated.CAH patients may require sodium chloride supplementation [18].Consider sodium benzoate for sodium replacement after discussion with an endocrinologist.\n\n",
            "cite_spans": [
                {
                    "start": 334,
                    "end": 336,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 476,
                    "end": 478,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Treatment ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nMany metabolic disorders require long-term dietary supplementation or restriction.\n",
            "cite_spans": [],
            "section": "Prognosis ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nNewborn screening should be administered on all newborns in the first 3 days of life.\n",
            "cite_spans": [],
            "section": "Prevention ::: Section E: Metabolic Emergencies",
            "ref_spans": []
        },
        {
            "text": "Bruising, bleeding, and petechiae are not common presenting issues in newborns, though when present, should raise concern. Broad differentials should be maintained for these clinical features.",
            "cite_spans": [],
            "section": "Introduction ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nIn neonatal alloimmune thrombocytopenia, maternal antibodies cross the placenta and target paternally derived antigens, causing destruction of the platelet.Autoimmune thrombocytopenia occurs when maternal antibodies target maternal and neonatal platelets.\n",
            "cite_spans": [],
            "section": "Pathophysiology ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nPatients may present with easy bleeding, petechiae, and purpura.Assess if males experienced prolonged bleeding with circumcision.\nMental status changes could be indicative of intracranial haemorrhage.\n",
            "cite_spans": [],
            "section": "Clinical Features ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nConsider vitamin K deficiency, neonatal alloimmune thrombocytopenia, and autoimmune thrombocytopenia.Also consider nonaccidental trauma, infection, underlying coagulopathy, necrotizing enterocolitis, haemophagocytic lymphohistiocytosis, and leukaemia.\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nGather thorough history including maternal medications, illnesses, birth history, and vitamin K administration.Obtain complete blood count, coagulation panel.Maintain a low threshold for infectious workupCranial computerised tomography (CT) scan or ultrasound should be completed if concerned for intracranial bleed.Consider haematology/oncology consult.\n",
            "cite_spans": [],
            "section": "Investigations ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nImmediately administer vitamin K if not previously given or coagulopathy is suspected.Vitamin K: 0.5\u20131 mg intramuscularly, subcutaneously, or intravenously [10]\nProvide platelet transfusion if patient is thrombocytopenic and actively bleeding (Table 11.12).\nConsider fresh frozen plasma in setting of moderate to severe bleeding.If concerned for an antibody-mediated process, consider intravenous immunoglobulin (IVIg) and/or platelet transfusion [19, 20].IVIg: 0.4\u20131 g/kg/day [19, 20].Steroid infusion can be considered as adjunct therapy [19, 20].\nAntibiotic therapy for infants with suspected bacterial infection\n",
            "cite_spans": [
                {
                    "start": 158,
                    "end": 160,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 449,
                    "end": 451,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 453,
                    "end": 455,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 479,
                    "end": 481,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 483,
                    "end": 485,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 542,
                    "end": 544,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 546,
                    "end": 548,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Treatment ::: Section F: Haematologic Emergencies",
            "ref_spans": [
                {
                    "start": 251,
                    "end": 256,
                    "mention": "11.12",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "\nIntracranial haemorrhage and lower platelet levels are associated with increased risk of morbidity and mortality [21].Majority of newborns with thrombocytopenia have good outcomes [21].\n",
            "cite_spans": [
                {
                    "start": 115,
                    "end": 117,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 182,
                    "end": 184,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Prognosis ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nAdministration of vitamin K immediately following birthClose monitoring of infants born to moms with idiopathic thrombocytopenia\n",
            "cite_spans": [],
            "section": "Prevention ::: Section F: Haematologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "Seizures may present in the neonatal period as a secondary process or as a primary seizure disorder. The primary goal after stabilisation of the patient should be to uncover and manage the underlying aetiology of the seizure.",
            "cite_spans": [],
            "section": "Introduction ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nSeizures are more frequent in preterm infants and infants with hypoxic ischemic encephalopathy (HIE) [22].Abnormal movements occur secondary to withdrawal from maternal drug exposure, commonly opioids.\n",
            "cite_spans": [
                {
                    "start": 103,
                    "end": 105,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Pathophysiology ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nSeizures may manifest with abnormal extremity or eye movements.Withdrawal symptoms are listed in Table 11.13 [23].\nNeonatal abstinence scoring may be utilised to assess for risk of neonatal withdrawal.\n\n",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 113,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Clinical Features ::: Section G: Neurologic Emergencies",
            "ref_spans": [
                {
                    "start": 104,
                    "end": 109,
                    "mention": "11.13",
                    "ref_id": "TABREF4"
                }
            ]
        },
        {
            "text": "\nAetiologies of seizure range from encephalopathy, stroke, HIE, metabolic disorders, infection, to genetic disorders [24].Electrolyte abnormality can present abnormal movements or behaviour.Nonaccidental trauma should always be considered.\n",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 120,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Differential Diagnosis ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nObtain glucose and electrolytes in infants with abnormal movements.Gather thorough history, including maternal history, maternal medications, maternal infections, and birth history [24].Obtain head imagingComplete infectious workup, including CSF studies, should be performed.Send urine and meconium toxicology screens to assess for withdrawal syndrome.\n",
            "cite_spans": [
                {
                    "start": 183,
                    "end": 185,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Investigations ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nIf hypoglycaemia is present, correct with IV dextrose.Consider treating a seizing neonate with phenobarbital or phenytoin [24].If seizures are nonresponsive to the above medications, please consider lorazepam or levetiracetam.In cases of neonatal withdrawal, provide supportive care and tailor medical management based on maternally abused drug (Table 11.13).\n",
            "cite_spans": [
                {
                    "start": 124,
                    "end": 126,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Treatment ::: Section G: Neurologic Emergencies",
            "ref_spans": [
                {
                    "start": 353,
                    "end": 358,
                    "mention": "11.13",
                    "ref_id": "TABREF4"
                }
            ]
        },
        {
            "text": "\nPrognosis depends on the underlying aetiology and duration of symptoms [24, 25].\n",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 75,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 77,
                    "end": 79,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Prognosis ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        },
        {
            "text": "\nMaternal education on the harms of drug use\n",
            "cite_spans": [],
            "section": "Prevention ::: Section G: Neurologic Emergencies",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 11.1: Signs of respiratory distress versus respiratory failure\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 11.10: Trigger levels of total serum bilirubin for phototherapy and exchange transfusion in infants 35 weeks or greater [12]\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 11.11: Characteristics of duodenal atresia, Hirschsprung\u2019s disease, and necrotizing enterocolitis\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 11.12: Potential triggers for platelet transfusion\n",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table 11.13: Comparison of neonatal seizures and withdrawal syndrome\n",
            "type": "table"
        },
        "TABREF5": {
            "text": "Table 11.2: Comparison of clinical features and management of RDS and bronchiolitis\n",
            "type": "table"
        },
        "TABREF6": {
            "text": "Table 11.3: Chest x-ray findings in common newborn respiratory diseases\n",
            "type": "table"
        },
        "TABREF7": {
            "text": "Table 11.4: Recommended interventions based on level of respiratory distress\n",
            "type": "table"
        },
        "TABREF8": {
            "text": "Table 11.5: Characteristics of cyanotic heart lesions\n\nVSD ventricular septal defect, Echo echocardiogram, CT computerised tomography, CXR chest x-ray, CR cardiorespiratory, PGE1 prostaglandin E1\n",
            "type": "table"
        },
        "TABREF9": {
            "text": "Table 11.6: Non-cyanotic heart defects\n\nBLE bilateral lower extremities",
            "type": "table"
        },
        "TABREF10": {
            "text": "Table 11.7: Possible clinical features associated with congenital heart disease\n\nbpm beats per minute, RA room air",
            "type": "table"
        },
        "TABREF11": {
            "text": "Table 11.8: Risk factors for hyperbilirubinemia\n",
            "type": "table"
        },
        "TABREF12": {
            "text": "Table 11.9: Classifying newborns into risk category based on age and number of risk factors\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig. 11.1: Assessment of infant colour and central pulses",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Neonatal resuscitation: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kattwinkel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Aziz",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Colby",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Fairchild",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Pediatrics",
            "volume": "126",
            "issn": "5",
            "pages": "1400-13",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2010-2972E"
                ]
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Division of bacterial diseases, national center for immunization and respiratory diseases. Prevention of perinatal group B streptococcal disease \u2013 revised guidelines from CDC",
            "authors": [
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Verani",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "McGee",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Schrag",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "MMWR Recomm Rep",
            "volume": "59",
            "issn": "RR10",
            "pages": "1-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation",
            "authors": [],
            "year": 2004,
            "venue": "Pediatrics",
            "volume": "114",
            "issn": "1",
            "pages": "297-316",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.114.1.297"
                ]
            }
        },
        "BIBREF4": {
            "title": "Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh",
            "authors": [
                {
                    "first": "CH",
                    "middle": [],
                    "last": "Rasul",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hasan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Yasmin",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Malays J Med Sci",
            "volume": "17",
            "issn": "2",
            "pages": "40-4",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Kuenzler",
                    "suffix": ""
                },
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Rothenberg",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Duodenal atresia. Fundamentals of pediatric surgery",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "The role of parenteral nutrition following surgery for duodenal atresia or stenosis",
            "authors": [
                {
                    "first": "M1",
                    "middle": [],
                    "last": "Bishay",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lakshminarayanan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Arnaud",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Garriboli",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Cross",
                    "suffix": ""
                },
                {
                    "first": "JI",
                    "middle": [],
                    "last": "Curry",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Pediatr Surg Int",
            "volume": "29",
            "issn": "2",
            "pages": "191-5",
            "other_ids": {
                "DOI": [
                    "10.1007/s00383-012-3200-9"
                ]
            }
        },
        "BIBREF7": {
            "title": "Hirschsprung\u2019s disease in Japan: analysis of 3852 patients based on a nationwide survey in 30 years",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Suita",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Taguchi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ieiri",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakatsuji",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Pediatr Surg",
            "volume": "40",
            "issn": "1",
            "pages": "197-201",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jpedsurg.2004.09.052"
                ]
            }
        },
        "BIBREF8": {
            "title": "Diagnostic tests in Hirschsprung disease: a systematic review",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "DeLorijn",
                    "suffix": ""
                },
                {
                    "first": "LCM",
                    "middle": [],
                    "last": "Kremer",
                    "suffix": ""
                },
                {
                    "first": "JB",
                    "middle": [],
                    "last": "Reitsma",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Benninga",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Pediatr Gastroenterol Nutr",
            "volume": "42",
            "issn": "",
            "pages": "496-505",
            "other_ids": {
                "DOI": [
                    "10.1097/01.mpg.0000214164.90939.92"
                ]
            }
        },
        "BIBREF9": {
            "title": "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline",
            "authors": [
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Speiser",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Azziz",
                    "suffix": ""
                },
                {
                    "first": "LS",
                    "middle": [],
                    "last": "Baskin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ghizzoni",
                    "suffix": ""
                },
                {
                    "first": "TW",
                    "middle": [],
                    "last": "Hensle",
                    "suffix": ""
                },
                {
                    "first": "DP",
                    "middle": [],
                    "last": "Merke",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Clin Endocrinol Metab",
            "volume": "95",
            "issn": "9",
            "pages": "4133-60",
            "other_ids": {
                "DOI": [
                    "10.1210/jc.2009-2631"
                ]
            }
        },
        "BIBREF10": {
            "title": "Management of severe alloimmune thrombocytopenia in the newborn",
            "authors": [
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Ouwehand",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ranasinghe",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arch Dis Child Fetal Neonatal Ed",
            "volume": "82",
            "issn": "3",
            "pages": "F173-5",
            "other_ids": {
                "DOI": [
                    "10.1136/fn.82.3.F173"
                ]
            }
        },
        "BIBREF11": {
            "title": "Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Mansbach",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Piedra",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Teach",
                    "suffix": ""
                },
                {
                    "first": "AF",
                    "middle": [],
                    "last": "Sullivan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Forgey",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Arch Pediatr Adolesc Med",
            "volume": "166",
            "issn": "8",
            "pages": "700-6",
            "other_ids": {
                "DOI": [
                    "10.1001/archpediatrics.2011.1669"
                ]
            }
        },
        "BIBREF12": {
            "title": "Alternative therapies for neonatal autoimmune thrombocytopenia",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ovali",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Samanci",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ermis",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Akdogan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dagoglu",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Vox Sang",
            "volume": "74",
            "issn": "3",
            "pages": "198-200",
            "other_ids": {
                "DOI": [
                    "10.1046/j.1423-0410.1998.7430198.x"
                ]
            }
        },
        "BIBREF13": {
            "title": "Platelets and Neonatal Transfusion Study Group. Prospective, observational study of outcomes in neonates with severe thrombocytopenia",
            "authors": [
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Stanworth",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Watts",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ballard",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Choo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Pediatrics",
            "volume": "124",
            "issn": "5",
            "pages": "e826-34",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2009-0332"
                ]
            }
        },
        "BIBREF14": {
            "title": "The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study",
            "authors": [
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Ronen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Penney",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Andrews",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Pediatr",
            "volume": "134",
            "issn": "1",
            "pages": "71-5",
            "other_ids": {
                "DOI": [
                    "10.1016/S0022-3476(99)70374-4"
                ]
            }
        },
        "BIBREF15": {
            "title": "Committee on drugs, committee on fetus and newborn, American Academy of Pediatrics. Neonatal drug withdrawal",
            "authors": [
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Hudak",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Pediatrics",
            "volume": "129",
            "issn": "2",
            "pages": "e540-60",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2011-3212"
                ]
            }
        },
        "BIBREF16": {
            "title": "Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries",
            "authors": [
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Co",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Elia",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Engel",
                    "suffix": "Jr"
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Guerrini",
                    "suffix": ""
                },
                {
                    "first": "EM",
                    "middle": [],
                    "last": "Mizrahi",
                    "suffix": ""
                },
                {
                    "first": "SL",
                    "middle": [],
                    "last": "Mosh\u00e9",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Epilepsia",
            "volume": "48",
            "issn": "6",
            "pages": "1158-64",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1528-1167.2007.01008.x"
                ]
            }
        },
        "BIBREF17": {
            "title": "Long-term prognosis in children with neonatal seizures: a population-based study",
            "authors": [
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Ronen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Buckley",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Penney",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Streiner",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Neurology",
            "volume": "69",
            "issn": "19",
            "pages": "1816-22",
            "other_ids": {
                "DOI": [
                    "10.1212/01.wnl.0000279335.85797.2c"
                ]
            }
        },
        "BIBREF18": {
            "title": "Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis",
            "authors": [
                {
                    "first": "SL",
                    "middle": [],
                    "last": "Ralston",
                    "suffix": ""
                },
                {
                    "first": "AS",
                    "middle": [],
                    "last": "Lieberthal",
                    "suffix": ""
                },
                {
                    "first": "HC",
                    "middle": [],
                    "last": "Meissner",
                    "suffix": ""
                },
                {
                    "first": "BK",
                    "middle": [],
                    "last": "Alverson",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Baley",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Gadomski",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Pediatrics",
            "volume": "134",
            "issn": "5",
            "pages": "e1474-502",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2014-2742"
                ]
            }
        },
        "BIBREF19": {
            "title": "Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials",
            "authors": [
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Kendig",
                    "suffix": ""
                },
                {
                    "first": "RH",
                    "middle": [],
                    "last": "Notter",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cox",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Aschner",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Benn",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Bernstein",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Pediatrics",
            "volume": "82",
            "issn": "5",
            "pages": "756-62",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Canadian Perinatal Surveillance System (Public Health Agency of Canada)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Joseph",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lisonkova",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rouleau",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van den Hof",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sauve",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Circulation",
            "volume": "128",
            "issn": "6",
            "pages": "583-9",
            "other_ids": {
                "DOI": [
                    "10.1161/CIRCULATIONAHA.112.001054"
                ]
            }
        },
        "BIBREF21": {
            "title": "Neonatal meningitis in England and Wales: sequelae at 5 years of age",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "de Louvois",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Halket",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Harvey",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Eur J Pediatr",
            "volume": "164",
            "issn": "12",
            "pages": "730-4",
            "other_ids": {
                "DOI": [
                    "10.1007/s00431-005-1747-3"
                ]
            }
        },
        "BIBREF22": {
            "title": "Neonatal meningitis in England and Wales: 10 years on",
            "authors": [
                {
                    "first": "DE",
                    "middle": [],
                    "last": "Holt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Halket",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "de Louvois",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Harvey",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Arch Dis Child Fetal Neonatal Ed",
            "volume": "84",
            "issn": "2",
            "pages": "F85-9",
            "other_ids": {
                "DOI": [
                    "10.1136/fn.84.2.F85"
                ]
            }
        },
        "BIBREF23": {
            "title": "Pathology of neonatal necrotizing enterocolitis: a ten-year experience",
            "authors": [
                {
                    "first": "WA",
                    "middle": [],
                    "last": "Ballance",
                    "suffix": ""
                },
                {
                    "first": "BB",
                    "middle": [],
                    "last": "Dahms",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Shenker",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Kliegman",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Pediatr",
            "volume": "117",
            "issn": "1 Pt 2",
            "pages": "6-13",
            "other_ids": {
                "DOI": [
                    "10.1016/S0022-3476(05)81124-2"
                ]
            }
        },
        "BIBREF24": {
            "title": "Microbiology and management of neonatal necrotizing enterocolitis",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Brook",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Perinatol",
            "volume": "25",
            "issn": "2",
            "pages": "111-8",
            "other_ids": {
                "DOI": [
                    "10.1055/s-2008-1040346"
                ]
            }
        }
    }
}